generic drugs
The latest news about generic drugs: headlines, AI summaries and the full story from every source.
- Dr. Reddy's Laboratories Receives FDA Tentative Approval for Generic Version of Gilead's Yeztugo
- Viatris Sues Novo Nordisk Over Generic Version of Wegovy
- Aurinia Pharmaceuticals and Teva Settle Patent Dispute Over LUPKYNIS
- Merck Signs Licensing Deals for New Experimental HIV Pill
- Trump Proposes 100% Tariffs on Imported Generic Medications
- Indian Pharma CEO Warns U.S. Tariffs Could Raise Generic Drug Prices
- Trump Proposes Tariffs on Imported Generic Drugs, Impact Uncertain
- Trump Announces Phased Tariff Plan on Generic Drug Imports Starting in 2028
- Trump Announces Phased Tariff Plan on Generic Drugs Starting in 2028
- Dr Reddy's Laboratories Faces Share Price Drop Due to Semaglutide Supply Issues
- Hims Launches Generic Version of Novo Nordisk's Semaglutide in Canada
- Takeda Found Guilty in Pay-for-Delay Scheme Over Amitiza
- Canada Approves Second Generic Version of Ozempic
- Pfizer Secures Patent Extension for Vyndamax, Delaying Generic Competition
- Novartis Q1 Sales Decline Reflects Industry Challenges with Generics and Patent Expirations